Cargando…
Changes of Serum Angiotensin-Converting Enzyme Activity During Treatment of Patients with Graves’ Disease(*)
Serum angiotensin-converting enzyme activity was measured spectrophotometrically, and serum thyrotropin-binding-inhibitory immunoglobulin (TBII) activity was measured by radioreceptor assay in normal subjects and in patients with Graves’ disease serially before and during treatment, and these activi...
Autores principales: | Lee, Dong Soo, Chung, June-Key, Cho, Bo Youn, Koh, Chang-Soon, Lee, Munho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534898/ https://www.ncbi.nlm.nih.gov/pubmed/15759385 http://dx.doi.org/10.3904/kjim.1986.1.1.104 |
Ejemplares similares
-
Changes in the Properties of the Thyrotropin Receptor Antibody in Patients with Graves’ Disease after Radioiodine Treatment
por: Cho, Bo Youn, et al.
Publicado: (1990) -
Relationships between Angiotensin I Converting Enzyme Gene Polymorphism and Renal Complications in Korean IDDM Patients(*)
por: Oh, Tae Geun, et al.
Publicado: (1996) -
HLA-DR Antigen Expression on the Thyrocytes of Graves’ Disease Patients
por: Lee, Myung Shik, et al.
Publicado: (1988) -
Serum Angiotensin Converting Enzyme in Pemphigus Vulgaris
por: Robati, Reza M, et al.
Publicado: (2014) -
Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and
Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney
Disease
por: MITANI, Sawane, et al.
Publicado: (2013)